TELA BIO INC. - COMMO

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

09 5月 2025 16:05:00 条件 Nasdaq GlobeNewswire

TELA Bio Reports First Quarter 2025 Financial Results

08 5月 2025 16:03:29 条件 Nasdaq GlobeNewswire

TELA Bio to Announce First Quarter 2025 Financial Results

17 4月 2025 16:05:00 条件 Nasdaq GlobeNewswire

TELA Bio Announces U.S. Commercial Launch of Larger Sizes of OviTex® PRS for Plastic and Reconstructive Surgery

31 3月 2025 07:00:00 条件 Nasdaq GlobeNewswire

TELA Bio Reports Fourth Quarter and Full Year 2024 Financial Results

20 3月 2025 16:05:00 条件 Nasdaq GlobeNewswire

TELA Bio to Announce Fourth Quarter and Full Year 2024 Financial Results

27 2月 2025 16:05:00 条件 Nasdaq GlobeNewswire

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

21 2月 2025 16:05:00 条件 Nasdaq GlobeNewswire

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

24 1月 2025 16:05:00 条件 Nasdaq GlobeNewswire

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

13 12月 2024 16:05:00 条件 Nasdaq GlobeNewswire

TELA Bio to Participate in Piper Sandler’s 36th Annual Healthcare Conference

19 11月 2024 16:05:00 条件 Nasdaq GlobeNewswire

TELA Bio Reports Third Quarter 2024 Financial Results

07 11月 2024 16:05:01 条件 Nasdaq GlobeNewswire

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 11月 2024 16:05:00 条件 Nasdaq GlobeNewswire

TELA Bio Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

24 10月 2024 16:05:00 条件 Nasdaq GlobeNewswire

TELA Bio Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants

23 10月 2024 08:07:00 条件 Nasdaq GlobeNewswire

TELA Bio Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

22 10月 2024 16:05:44 条件 Nasdaq GlobeNewswire

TELA Bio to Announce Third Quarter 2024 Financial Results

17 10月 2024 16:05:00 条件 Nasdaq GlobeNewswire

TELA Bio Reports Second Quarter 2024 Financial Results and Reiterates Full Year 2024 Revenue Guidance

12 8月 2024 16:05:00 条件 Nasdaq GlobeNewswire

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

09 8月 2024 16:05:00 条件 Nasdaq GlobeNewswire

TELA Bio to Participate in the Canaccord Genuity 44th Annual Growth Conference

25 7月 2024 16:05:00 条件 Nasdaq GlobeNewswire

TELA Bio to Announce Second Quarter 2024 Financial Results

22 7月 2024 16:05:00 条件 Nasdaq GlobeNewswire